New oral Alzheimer's drug begins first human safety tests
Knowledge-focused
Recruiting now
This early-stage study tests an experimental oral drug called AS-S603, designed to target proteins linked to Alzheimer's disease. The main goal is to check the drug's safety and how the body processes it in 88 healthy adults, including Korean and Caucasian volunteers and older Ko…
Phase: PHASE1 • Sponsor: Amyloid Solution Inc • Aim: Knowledge-focused
Last updated May 16, 2026 23:33 UTC